top of page
이미지 제공: Markus Spiske

Investor Relations

FINANCIAL INFORMATION

CONSOLIDATED BALANCE SHEET

(Unit: million won)

Category
2020
2021
2022
2023
Current Assets (Total)
64,913
67,519
75,655
81,929
Non-Current Assets
40,389
45,357
40,184
35,712
Total Assets
105,301
112,877
115,839
117,641
Current Liabilities
4,630
5,766
7,389
4,821
Non-Current Liabilities
686
423
358
934
Total Liabilities
5,317
6,189
7,747
5,755
Capital Stock
4,700
4,700
4,700
4,700
Capital Surplus
12,760
12,760
12,760
12,760
Retained Earnings
102,696
109,894
114,993
118,217
Total Equity
99,985
106,687
108,092
111,885

CONSOLIDATED INCOME STATEMENT

(Unit: million won)

Category
2020
2021
2022
2023
Sales Revenue
45,582
46,873
50,526
53,787
Gross Profit
34,725
35,683
37,951
38,975
Operating Income
3,667
7,257
6,051
2,195
Income Before Tax
2,402
12,090
10,172
6,880
Net Income
3,189
10,383
8,281
6,304

CONSOLIDATED CASH FLOW STATEMENT

(Unit: million won)

Category
2020
2021
2022
2023
Cash Flows from Operating Activities
9,564
14,892
12,814
7,815
Cash Flows from Investing Activities
-1,627
-11,132
-6,669
-4,745
Cash Flows from Financing Activities
-7,616
-3,858
-7,538
-3,721
Increase (Decrease) in Cash
177
260
-1,402
-574
Beginning Cash Balance
9,422
9,600
9,860
8,458
Ending Cash Balance
9,600
9,860
8,458
7,884

DISCLOSURE

Date
Report Name
보고서명
Submitter
27/02/2025
Resolution on Convening the General Meeting of Shareholders
주주총회소집결의
Cell Biotech
27/02/2025
Report on the Reason for Holding the General Meeting of Shareholders on a Concentrated Date
주주총회집중일개최사유신고
Cell Biotech
19/02/2025
Decision on Cash or In-kind Dividend
현금ㆍ현물배당결정
Cell Biotech
19/02/2025
Change in Sales Revenue or Profit Structure by 30% (15% for Large Corporations) or More
매출액또는손익구조30%(대규모법인은15%)이상변동
Cell Biotech
12/02/2025
Report on the Status of Ownership of Specific Securities by Executives and Major Shareholders
임원ㆍ주요주주특정증권등소유상황보고서
Lee Sang-hoon
06/02/2025
Report on the Status of Ownership of Specific Securities by Executives and Major Shareholders
임원ㆍ주요주주특정증권등소유상황보고서
Yoon Sung-bae
16/12/2024
Setting the Period for Closing the Shareholders’ Register or the Record Date
주주명부폐쇄기간또는기준일설정
Cell Biotech
10/12/2024
Investor Relations (IR) Presentation
기업설명회(IR)개최
Cell Biotech
25/11/2024
Investor Relations (IR) Presentation
기업설명회(IR)개최
Cell Biotech
19/11/2024
Investor Relations (IR) Presentation
기업설명회(IR)개최
Cell Biotech
14/11/2024
Quarterly Report (Q3 2024)
분기보고서 (2024.09)
Cell Biotech
06/11/2024
Operating Results Based on Consolidated Financial Statements
연결재무제표기준영업(잠정)실적(공정공시)
Cell Biotech
02/09/2024
Corporate Presentation (IR)
기업설명회(IR)개최
Cell Biotech
16/08/2024
Corporate Presentation (IR)
기업설명회(IR)개최
Cell Biotech
14/08/2024
Semiannual Report (2024.06)
반기보고서 (2024.06)
Cell Biotech
07/08/2024
Corporate Presentation (IR)
기업설명회(IR)개최
Cell Biotech
06/08/2024
Operating Results Based on Consolidated Financial Statements
연결재무제표기준영업(잠정)실적(공정공시)
Cell Biotech
01/08/2024
Corporate Presentation (IR)
기업설명회(IR)개최
Cell Biotech
22/07/2024
Corporate Presentation (IR)
기업설명회(IR)개최
Cell Biotech
16/07/2024
Corporate Presentation (IR)
기업설명회(IR)개최
Cell Biotech
09/07/2024
Corporate Presentation (IR)
기업설명회(IR)개최
Cell Biotech
28/06/2024
Corporate Presentation (IR)
기업설명회(IR)개최
Cell Biotech
26/06/2024
Other Market Announcement (Notice of Industry Change)
기타시장안내 (업종변경 안내)
KOSDAQ
16/05/2024
Quarterly Report (2024.03)
분기보고서 (2024.03)
Cell Biotech
08/05/2024
Operating Results Based on Consolidated Financial Statements
연결재무제표기준영업(잠정)실적(공정공시)
Cell Biotech
30/04/2024
Change of Affiliated Division
소속부변경
KOSDAQ

Copyright (c) 2024 Cell Biotech. All rights reserved.

HEADQUARTER

CELL BIOTECH  

Address

50, Aegibong-ro 409beon-gil, Gaegok-ri, Wolgot-myeon, Gimpo-si, Gyeonggi-do, Republic of Korea


Tel

(+82)31-987-6205 

SALES/MARKETING

CELL BIOTECH INTERNATIONAL

Address

3F, Bluecom Tower, Seocho-daero 274, Seocho-gu, Seoul, 06645, Korea

Tel

(+82)-2-2668-6077 

EUROPE OFFICE

CELL BIOTECH INTERNATIONAL A/S

Address

Strandvejen 125, DK-2900 Hellerup, Denmark

Tel

(+45) 3977-5040

bottom of page